Cancer therapy
US9834575B2 · kind B2 · utility
0Cited by
40References
23Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 26, 2014 |
| Grant date | Dec 5, 2017 |
| Priority date | — |
| Expiry date | May 21, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H15/203
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present application relates to compositions and methods for treating a proliferative disorder by administering to a subject a pharmaceutical composition of a dual kinase inhibitor metabolite. Catecholic butane metabolites can serve as dual kinase inhibitors for purposes of methods described herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.